×
About 17,563 results

ALLMedicine™ Hepatitis C Virus Center

Research & Reviews  6,473 results

Meta-analysis: Risk of hepatitis C virus infection associated with hospital-based invas...
https://doi.org/10.1111/apt.17106
Alimentary Pharmacology & Therapeutics; Henriot P, Castry M et. al.

Jun 28th, 2022 - Healthcare settings, where invasive procedures are frequently performed, may play an important role in the transmission dynamics of blood-borne pathogens when compliance with infection control precautions is suboptimal. To understand and quantify ...

Global Trends and The Impact of Chronic Hepatitis B and C on Disability-Adjusted Life Y...
https://doi.org/10.1111/liv.15347
Liver International : Official Journal of the Internation... Veracruz N, Gish RG et. al.

Jun 27th, 2022 - Advances in hepatitis B virus (HBV) and hepatitis C virus (HCV) therapies have improved morbidity and mortality, but global disparities in viral hepatitis outcomes remain. We evaluate global trends in the impact of HBV and HCV on disability adjust...

Performance of rapid test for antibodies to hepatitis C virus (anti-HCV) in hemodialysi...
https://doi.org/10.1177/03913988221104834
The International Journal of Artificial Organs; Becker SCDC, Medina-Pestana JO et. al.

Jun 26th, 2022 - Rapid tests (RT) have been widely used for screening of hepatitis C virus (HCV) in general population, but its performance in hemodialysis (HD) patients and mainly in kidney-transplant recipients (RTx) is less known. The aim of this study was to e...

Utilizing Telemedicine and Modified Fibrosis Staging Protocols to Maintain Treatment In...
https://doi.org/10.1177/21501319221108000
Journal of Primary Care & Community Health; O'Brien M, Daws R et. al.

Jun 25th, 2022 - The COVID-19 pandemic exacerbated the decline in Hepatitis C Virus (HCV) screening and treatment globally in part due to lockdowns and restrictions at healthcare centers. The goal of this retrospective cohort study was to assess the effectiveness ...

Implementation of a Controlled Human Infection Model for Evaluation of HCV Vaccine Cand...
https://doi.org/10.1002/hep.32632
Hepatology (Baltimore, Md.); Barnes E, Cooke GS et. al.

Jun 24th, 2022 - Hepatitis C virus (HCV) remains a major global health concern. Directly acting antiviral (DAA) drugs have transformed the treatment of HCV. However, it has become clear that without an effective HCV vaccine it will not be possible to meet the WHO ...

see more →

Guidelines  14 results

Non-invasive diagnosis and follow-up of chronic infection with Hepatitis C Virus.
https://doi.org/10.1016/j.clinre.2021.101771
Clinics and Research in Hepatology and Gastroenterology; Tran A, Shili-Masmoudi S et. al.

Aug 1st, 2021 - Hepatitis C virus (HCV) infection is a major cause of chronic liver disease. Clinical care for patients with HCV-related liver disease has advanced considerably with developments in screening, diagnostic procedures to evaluate liver fibrosis and i...

EASL recommendations on treatment of hepatitis C: Final update of the series☆.
https://doi.org/10.1016/j.jhep.2020.08.018
Journal of Hepatology; , et. al.

Sep 22nd, 2020 - Hepatitis C virus (HCV) infection is a major cause of chronic liver disease, with approximately 71 million chronically infected individuals worldwide. Clinical care for patients with HCV-related liver disease has advanced considerably thanks to an...

Screening for Hepatitis C Virus Infection in Adolescents and Adults: US Preventive Serv...
https://doi.org/10.1001/jama.2020.1123
JAMA , Owens DK et. al.

Mar 3rd, 2020 - Hepatitis C virus (HCV) is the most common chronic blood-borne pathogen in the US and a leading cause of complications from chronic liver disease. HCV is associated with more deaths than the top 60 other reportable infectious diseases combined, in...

Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C Virus Infection in Chro...
https://doi.org/10.7326/M19-1539
Annals of Internal Medicine; Gordon CE, Berenguer MC et. al.

Sep 24th, 2019 - This article has been corrected. The original version (PDF) is appended to this article as a Supplement. The Kidney Disease: Improving Global Outcomes (KDIGO) 2018 clinical practice guideline for the prevention, diagnosis, evaluation, and treatmen...

Management of hepatitis C virus infection in patients with chronic kidney disease: posi...
https://doi.org/10.1007/s40620-018-0523-1 10.1111/ctr.12941 10.1111/tid.12696
Journal of Nephrology; Minutolo R, Aghemo A et. al.

Sep 27th, 2018 - Hepatitis C virus (HCV) infection is now considered a systemic disease due to the occurrence of extra-hepatic manifestations. Among these, the renal involvement is frequent. HCV infection, in fact, is strongly associated with proteinuria and chron...

see more →

Drugs  18 results see all →

News  520 results

Protease Inhibitor–Based DAAs Appear Safe in Decompensated Patients
https://www.medscape.com/viewarticle/974504

May 24th, 2022 - SAN DIEGO – An analysis of a large, international cohort suggests that treatment with protease-inhibitor (PI)–based direct-acting antivirals (DAAs) may be safe for patients with hepatitis C virus (HCV) with cirrhosis and early-stage liver decompen...

DOJ Complaint Flags HCV Drug Denials for People With Addiction
https://www.medscape.com/viewarticle/973791

May 11th, 2022 - A complaint filed with the US Department of Justice (DOJ) alleges that Alabama's Medicaid program is illegally denying curative drug treatment for hepatitis C virus (HCV) infection to people with substance use disorder. The complaint was filed May...

To Engage Injection Drug Users in HCV Care, Go to Where They Are
https://www.medscape.com/viewarticle/970439

Mar 17th, 2022 - For injection drug users with hepatitis C virus (HCV) infection, providing treatment opportunities within a local needle exchange program can provide care to more patients and eventually cure more patients, a new study suggests. The study's findin...

HCV Screening in Pregnancy: Reducing the Risk for Casualties in the Quest for Elimination
https://www.medscape.com/viewarticle/963059

Nov 22nd, 2021 - Because hepatitis C virus (HCV) infection is typically asymptomatic, its presence can easily be overlooked without appropriate screening efforts. For those screening efforts to be effective, they must keep pace with the changing demographic face o...

Liver Cancer Risk Lingers Even After HCV Eradication
https://www.medscape.com/viewarticle/963101

Nov 17th, 2021 - Although the risk for liver cancer diminishes for patients with hepatitis C virus (HCV) infections for whom virus is eliminated with direct-acting antiviral (DAA) drugs, these patients are not out of the woods, and those who do not have a sustaine...

see more →